Molecular Diagnostics Market
完整報告名稱與涵蓋範圍
Molecular Diagnostics Market Size, Share & Trends Analysis Report, By Product (Reagents, Kits and Consumables, Instruments and Analyzers, Software, Services and Laboratory Developed Tests), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Isothermal Amplification and Other Nucleic Acid Technologies, Microarrays, In Situ Hybridization and Mass Spectrometry), By Application (Infectious Disease Testing, Oncology and Companion Diagnostics, Genetic, Prenatal and Rare Disease Testing, Pharmacogenomics and Other Applications), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The molecular diagnostics market covers reagents, kits and consumables, instruments and analyzers and software, services and laboratory developed tests based on nucleic acid detection and analysis, spanning PCR, next-generation sequencing, isothermal amplification, microarrays, in situ hybridisation and mass spectrometry, across infectious disease, oncology, genetic and prenatal testing and pharmacogenomics. Immunoassay and clinical chemistry diagnostics and research-only genomics tools are excluded; point-of-care molecular diagnostics are addressed in greater depth in a separate InsightAce study.
Demand has normalised after pandemic-era peaks and is now driven by respiratory syndromic panels and multiplex infectious disease testing, by oncology applications including tumor profiling, liquid biopsy and minimal residual disease monitoring, by expanded carrier and prenatal screening and by decentralised testing in hospitals and clinics. Sequencing costs continue to fall, digital PCR and rapid isothermal platforms broaden the technology base and automation and informatics reduce laboratory labour. Reimbursement for comprehensive genomic profiling, regulatory oversight of laboratory developed tests, antimicrobial stewardship programs and consolidation among laboratory operators shape the commercial environment.
North America and Europe generate most revenue, and Asia Pacific is the fastest-growing region as China, India, Japan and South Korea expand laboratory capacity and domestic manufacturing. Competition involves diversified diagnostic leaders, sequencing platform companies, specialised molecular test developers and Asian reagent manufacturers.
The InsightAce study provides US$ revenue forecasts for every product, technology, application and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular Diagnostics Market Snapshot
Chapter 4. Global Molecular Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. Product & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product:
5.2.1. Reagents, Kits and Consumables
5.2.2. Instruments and Analyzers
5.2.3. Software, Services and Laboratory Developed Tests
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. Technology & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology:
6.2.1. Polymerase Chain Reaction
6.2.2. Next-Generation Sequencing
6.2.3. Isothermal Amplification and Other Nucleic Acid Technologies
6.2.4. Microarrays, In Situ Hybridization and Mass Spectrometry
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Infectious Disease Testing
7.2.2. Oncology and Companion Diagnostics
7.2.3. Genetic, Prenatal and Rare Disease Testing
7.2.4. Pharmacogenomics and Other Applications
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Central Laboratories
8.2.2. Reference and Specialty Laboratories
8.2.3. Point-of-Care and Decentralized Settings
Chapter 9. Molecular Diagnostics Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Roche Holding AG
11.2. Abbott Laboratories
11.3. Thermo Fisher Scientific Inc.
11.4. Danaher Corporation (Cepheid)
11.5. Hologic, Inc.
11.6. bioMerieux SA
11.7. QIAGEN N.V.
11.8. Becton, Dickinson and Company
11.9. Illumina, Inc.
11.10. Bio-Rad Laboratories, Inc.
11.11. Siemens Healthineers AG
11.12. Seegene Inc.
11.13. Guardant Health, Inc.
11.14. Exact Sciences Corporation
11.15. Shanghai ZJ Bio-Tech Co., Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Molecular Diagnostics Market Revenue Forecast by Product, 2026-2035 (US$ Mn)
Figure 1. Global Molecular Diagnostics Market Segmentation Overview
Table 2. Global Molecular Diagnostics Market Revenue Forecast by Technology, 2026-2035 (US$ Mn)
Figure 2. Global Molecular Diagnostics Market Share by Product, 2026 & 2035
Table 3. Global Molecular Diagnostics Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Molecular Diagnostics Demand Normalisation and Growth Drivers After the Pandemic Peak, 2022-2035
Table 4. Global Molecular Diagnostics Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Molecular Diagnostics Market Share by Technology, 2026 & 2035
Table 5. North America Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Technology Mix Across PCR, Sequencing and Isothermal Platforms by Application
Table 6. Europe Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Molecular Diagnostics Growth Opportunity Analysis
Table 7. Asia Pacific Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Regulatory Oversight of Laboratory Developed Tests and Its Effect on Test Development
Table 8. Latin America Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Molecular Diagnostics Market Participants
Table 9. Middle East & Africa Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們